On January 16, 2026, the U.S. Supreme Court agreed to hear Hikma Pharmaceuticals USA, Inc. v. Amarin Pharma, Inc., a patent ...

The product was developed using STEERLife's FragMelt continuous processing platform, which enables solvent-free manufacturing while maintaining bioequivalence to the reference product.

Bionpharma's etravirine tablet for HIV/AIDS, developed on a continuous manufacturing platform, got Abbreviated New Drug ...

The U.S. Food and Drug Administration has delayed reviews of two drugs chosen for the Trump administration's new fast-track ...

The big news in the drug sector is the emergence of GLP-1 weight loss drugs, but dig deeper, and you'll find relatively cheap ...

IBSRELA + XPHOZAH fuel growth, patent runway to 2041, and pipeline upside. Read the full analysis here of ARDX stock.

The "Human Factors and Usability Engineering in the Development of Drug Delivery Products Training Course (Feb 11th - Feb 12th, 2026)" training has been added to ResearchAndMarkets.com's offering.

With ANDA approval secured, Bionpharma will lead the commercialization and distribution of Etravirine tablets in the United States. Both organizations view this achievement as a solid foundation for ...

The advent and proliferation of targeted modalities represent an evolutionary leap forward in drug development. By binding ...

During its third session, chaired by Saqr Ghobash (Speaker of the Council), the Federal National Council called for drug prices to be reduced, particularly ...

Taiwanese drugmaker ScinoPharm (TWSE: 1789) has secured approval from the US Food and Drug Administration for its glatiramer ...

The Singapore-based AI clinical trial engine powering Asia’s—especially China’s—rapid rise in the biotech industry. Deep ...